$AMBQ

Hanson Scott McLean sold $422K of AMBQ

Hanson Scott McLean (Chief Technology Officer) sold 7,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $60.28 ($59.53–$61.00, $0.42M total) across 3 trades on 2026-09-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hanson Scott McLean
Published Sep 17, 2026, 8:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMBQ
Neutral
high confidence
Mentioned
$AMBQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQNeutralLow
01

Why it matters

The transaction is modest and pre‑arranged, suggesting minimal immediate market impact.

02

Market read

Provides a fresh insider transaction record for AMBQ, useful for monitoring insider activity but low trading relevance.

03

What to watch

Potential upcoming dilution from financing activities could affect share ownership dynamics.

Relevance 3/10Novelty 3/10Timing: filed Sep 17 2026

Background

Form 4 filings disclose insider transactions; this filing reports a routine sale by the CTO.

Company-level read

Ticker impact

$AMBQNeutralHigh confidence
Context

CTO Hanson Scott McLean sold 7,000 shares for $421,942 via a 10b5‑1 plan, reducing his stake to 221,226 shares.

Expected impact

Potential slight downward pressure, but unlikely to move the stock materially.

Evidence & confidence

Sale size is modest relative to market cap and executed under a pre‑arranged plan, indicating no urgent information.

Market effects

No broader sector impact; insider sales are routine in semiconductor equipment space.

None

Limited to investors tracking Ambiq Micro.

Counterpoint

The sale could be a signal of upcoming product or financial challenges not yet public.

Key entities

  • Ambiq Micro, Inc.

    US‑listed semiconductor firm (ticker AMBQ).

  • Hanson Scott McLean

    Chief Technology Officer of Ambiq Micro.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.